Feb. 3, 2023 Price forecast | 2 weeks: -2.35% | 1 month: -1.61% | 3 months: -5.47%


NGM stock forecast

Our latest prediction for Ngm Biopharmaceuticals Inc's stock price was made on the Feb. 3, 2023 when the stock price was at 5.40$.

In the short term (2weeks), NGM's stock price should underperform the market by -2.35%. During that period the price should oscillate between -9.74% and +7.42%.

In the medium term (3months), NGM's stock price should underperform the market by -5.47%. During that period the price should oscillate between -28.97% and +18.25%.

Create a solid portfolio with NGM

Add NGM to your portfolio and optimize it!


About Ngm Biopharmaceuticals Inc

NGM is a biopharmaceutical company focused on discovering and developing novel therapeutics based on scientific understanding of key biological pathways underlying liver and metabolic diseases, retinal diseases and cancer. The Company leverages its biology-centric drug discovery approach to uncover novel mechanisms of action and generate proprietary insights that enable it to move rapidly into proof-of-concept studies and deliver potential first-in-class medicines to patients. NGM aspires to operate one of the most productive research and development engines in the biopharmaceutical industry.

At the moment the company generates 231M USD in revenues.

On its last earning announcement, the company reported a loss of -1.38$ per share.

The book value per share is 2.88$

Ngm Biopharmaceuticals Inc website


Three months stock forecastFeb. 3, 2023


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
231M 25.13% -155M -67.12% -103M -1.38 - - 81M 2.88 - - -